Qube Research & Technologies (QRT)
CKPT

Qube Research & Technologies (QRT)’s Checkpoint Therapeutics CKPT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-71,260
Closed -$288K – 3587
2025
Q1 		$288K Buy
71,260
+26,823
+60% +$89.4K ﹤0.01% 2746
2024
Q4 		$142K Buy
+44,437
New +$151K ﹤0.01% 2915
2022
Q2 		– Sell
-4,181
Closed -$74K – 2566
2022
Q1 		$74K Sell
4,181
-163
-4% -$3.5K ﹤0.01% 2121
2021
Q4 		$135K Buy
+4,344
New +$144K ﹤0.01% 2070
2021
Q3 		– Sell
-2,306
Closed -$68K – 2269
2021
Q2 		$68K Buy
+2,306
New +$63.9K ﹤0.01% 1993

Qube Research & Technologies (QRT)'s CKPT Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 71,260 shares — an estimated $288K sold.

Qube Research & Technologies (QRT) first reported a position in CKPT in Q2 2021 and held it in 5 quarters. The position peaked at $288K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 71,260 Checkpoint Therapeutics shares in Q2 2025, an estimated $288K.
  • Qube Research & Technologies (QRT) first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Checkpoint Therapeutics position peaked at $288K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.